Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Other financing activities (2022)

Avanos Medical (AVNS) has disclosed Other financing activities for 3 consecutive years, with $2.3 million as the latest value for Q2 2022.

  • Quarterly Other financing activities changed N/A to $2.3 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Mar 2023, up 283.33% year-over-year, with the annual reading at $2.9 million for FY2022, N/A changed from the prior year.
  • Other financing activities hit $2.3 million in Q2 2022 for Avanos Medical, up from $600000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $2.3 million in Q2 2022 to a low of $600000.0 in Q1 2022.